Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Her is my answer from Hawk on the Royalty payment question

Greeneyes,

I think he means splitting the cost between 400 shareholders... provided that that many shareholders would participate in an organized group.

IMO...just a guess.

Regards,
PxP

Share
New Message
Please login to post a reply